| Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Mural Oncology plc | Chief Legal Officer and Secretary | Ordinary Shares | 43.9K | $150K | $3.41 | Jul 18, 2024 | Direct |
| Mural Oncology plc | Chief Legal Officer and Secretary | Stock Option (right to buy) | 31.2K | $105K | $3.35 | Mar 1, 2024 | Direct |
| Rubius Therapeutics, Inc. | CLO & Corp. Secretary | Stock Option (Right to Buy) | 144K | Jan 31, 2022 | Direct | ||
| Rubius Therapeutics, Inc. | CLO & Corp. Secretary | Restricted Stock Units | 34.5K | Jan 31, 2022 | Direct | ||
| Rubius Therapeutics, Inc. | CLO & Corp. Secretary | Common Stock | 5.34K | Feb 1, 2022 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
|---|---|---|---|---|---|---|---|
| MURA | Mural Oncology plc | Jul 18, 2024 | 1 | -$7.36K | 4 | Jul 18, 2024 | Chief Legal Officer and Secretary |
| MURA | Mural Oncology plc | Mar 1, 2024 | 2 | $0 | 4 | Mar 4, 2024 | Chief Legal Officer and Secretary |
| MURA | Mural Oncology plc | Dec 14, 2023 | 2 | $0 | 4 | Dec 18, 2023 | Chief Legal Officer and Secretary |
| MURA | Mural Oncology plc | Nov 15, 2023 | 0 | $0 | 3 | Nov 15, 2023 | Chief Legal Officer and Secretary Exhibit 24 - Power of Attorney |
| RUBY | Rubius Therapeutics, Inc. | Jan 29, 2022 | 5 | -$18K | 4 | Feb 1, 2022 | CLO & Corp. Secretary |